Algalithe P
Product description
Algalithe P®,
our patented excipient for probiotics with a low aW and Gastroresistant.
• Improved stability : All partners reported significant enhancements in product stability. In some cases, brands previously unable to meet label claims after 7–8 months - despite using 400–500% overages - are now maintaining potency for 24 to 33 months with no degradation. Simultaneously, these companies have been able to reduce overages to as low as 50%, resulting in substantial cost reductions. These trends have been consistent across multiple customers.
• Dosing discretion : While most partners have opted not to disclose the precise quantity of Algalithe P® used in their formulations, one has indicated successful results using 150–200 mg per capsule.
We typically suggest testing Algalithe P® at various inclusion levels (high, medium, low) with both current and reduced overage rates. While we anticipate different strains may respond to different levels of the excipient, the consistent outcome across tests has been a significant increase in stability and a correlated reduction in overages, both key to long-term cost optimization.
Read more
• Improved stability : All partners reported significant enhancements in product stability. In some cases, brands previously unable to meet label claims after 7–8 months - despite using 400–500% overages - are now maintaining potency for 24 to 33 months with no degradation. Simultaneously, these companies have been able to reduce overages to as low as 50%, resulting in substantial cost reductions. These trends have been consistent across multiple customers.
• Dosing discretion : While most partners have opted not to disclose the precise quantity of Algalithe P® used in their formulations, one has indicated successful results using 150–200 mg per capsule.
We typically suggest testing Algalithe P® at various inclusion levels (high, medium, low) with both current and reduced overage rates. While we anticipate different strains may respond to different levels of the excipient, the consistent outcome across tests has been a significant increase in stability and a correlated reduction in overages, both key to long-term cost optimization.
Specifications
| Categories | Fungi & Yeasts, Microorganisms & Probiotics, Mushrooms | Microorganisms & ProbioticsOther Microorganisms & Probiotics; Digestive Health |
|---|---|
| Sales markets | Western Europe; Eastern Europe; Middle East; Asia |
| Supplied from | Switzerland |
| Certifications | Health & Safety (GMP, HAACP and equivalents) |
More products from Straqim sa
Algalithe P
